Bilaketaren emaitzak - Adrian Bot

Findu emaitzak
  1. 1
    Protective Role of Gamma Interferon during the Recall Response to Influenza Virus

    Protective Role of Gamma Interferon during the Recall Response to Influenza Virus nork Adrian Bot, Simona Bot, Constantin A. Bona

    Argitaratua 1998
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Axicabtagene ciloleucel, a first-in-class CAR T cell therapy for aggressive NHL

    Axicabtagene ciloleucel, a first-in-class CAR T cell therapy for aggressive NHL nork Zachary Roberts, Marc Better, Adrian Bot, Margo R. Roberts, Antoni Ribas

    Argitaratua 2017
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Novel lipid-based hollow-porous microparticles as a platform for immunoglobulin delivery to the respiratory tract.

    Novel lipid-based hollow-porous microparticles as a platform for immunoglobulin delivery to the respiratory tract. nork Adrian Bot, Thomas E. Tarara, Daniel J. Smıth, Simona Bot, Catherine M. Woods, Jeffry G. Weers

    Argitaratua 2000
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Liquid biopsy approach to monitor the efficacy and response to CAR-T cell therapy

    Liquid biopsy approach to monitor the efficacy and response to CAR-T cell therapy nork Stephanie N. Shishido, Olivia Hart, Sujin Jeong, Aidan Moriarty, Darren Heeke, John M. Rossi, Adrian Bot, Peter Kühn

    Argitaratua 2024
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Plasmid Vaccination with Insulin B Chain Prevents Autoimmune Diabetes in Nonobese Diabetic Mice

    Plasmid Vaccination with Insulin B Chain Prevents Autoimmune Diabetes in Nonobese Diabetic Mice nork Adrian Bot, Daniel J. Smıth, Simona Bot, Anna C. Hughes, Tom Wolfe, Xin Lin, C. G. Woods, Matthias von Herrath

    Argitaratua 2001
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Autoreactive CD4+ T Cells Protect from Autoimmune Diabetes via Bystander Suppression Using the IL-4/Stat6 Pathway

    Autoreactive CD4+ T Cells Protect from Autoimmune Diabetes via Bystander Suppression Using the IL-4/Stat6 Pathway nork Dirk Homann, Andreas Holz, Adrian Bot, Bryan Coon, Tom Wolfe, Jacob Petersen, Thomas Dyrberg, Michael J. Grusby, Matthias G. von Herrath

    Argitaratua 1999
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    A Phase 1 Study of a Vaccine Targeting Preferentially Expressed Antigen in Melanoma and Prostate-specific Membrane Antigen in Patients With Advanced Solid Tumors

    A Phase 1 Study of a Vaccine Targeting Preferentially Expressed Antigen in Melanoma and Prostate-specific Membrane Antigen in Patients With Advanced Solid Tumors nork Jeffrey S. Weber, Nicholas J. Vogelzang, Marc S. Ernstoff, Oscar B. Goodman, Lee D. Cranmer, John L. Marshall, Sabrina Miles, Dar Rosario, David C. Diamond, Zhiyong Qiu, Mihail Obrocea, Adrian Bot

    Argitaratua 2011
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy

    Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy nork James N. Kochenderfer, Robert Somerville, Tangying Lu, James C. Yang, Richard M. Sherry, Steven A. Feldman, Lori McIntyre, Adrian Bot, John M. Rossi, Norris Lam, Steven A. Rosenberg

    Argitaratua 2017
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Intra–Lymph Node Prime-Boost Vaccination against Melan A and Tyrosinase for the Treatment of Metastatic Melanoma: Results of a Phase 1 Clinical Trial

    Intra–Lymph Node Prime-Boost Vaccination against Melan A and Tyrosinase for the Treatment of Metastatic Melanoma: Results of a Phase 1 Clinical Trial nork Antoni Ribas, Jeffrey S. Weber, Bartosz Chmielowski, Begonya Comin-Anduix, David Lu, Michael Douek, Nagesh Ragavendra, Steve Raman, Elizabeth Seja, Darlene Rosario, Sabrina Miles, David C. Diamond, Zhiyong Qiu, Mihail Obrocea, Adrian Bot

    Argitaratua 2011
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Antigen kinetics determines immune reactivity

    Antigen kinetics determines immune reactivity nork Pål Johansen, Tazio Storni, Lorna Rettig, Zhiyong Qiu, Ani Der-Sarkissian, Kevin M. Smith, Vania Manolova, Karl S. Lang, Gabriela Senti, Beat Müllhaupt, Tilman Gerlach, Roberto F. Speck, Adrian Bot, Thomas M. Kündig

    Argitaratua 2008
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Activation of CAR and non-CAR T cells within the tumor microenvironment following CAR T cell therapy

    Activation of CAR and non-CAR T cells within the tumor microenvironment following CAR T cell therapy nork Pei-Hsuan Chen, Mikel Lipschitz, Jason L. Weirather, Caron A. Jacobson, Philippe Armand, Kyle Wright, F. Stephen Hodi, Zachary Roberts, Stuart A. Sievers, John M. Rossi, Adrian Bot, William Y. Go, Scott J. Rodig

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL

    Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL nork John M. Rossi, Patrick Paczkowski, Yueh-wei Shen, Kevin Morse, Brianna Flynn, Alaina Kaiser, Colin Ng, Kyle Gallatin, Tom Cain, Rong Fan, Sean Mackay, James R. Heath, Steven A. Rosenberg, James N. Kochenderfer, Jing Zhou, Adrian Bot

    Argitaratua 2018
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

    Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma nork Frederick L. Locke, Sattva S. Neelapu, Nancy L. Bartlett, Tanya Siddiqi, Julio C. Chávez, Chitra Hosing, Armin Ghobadi, Lihua E. Budde, Adrian Bot, John M. Rossi, Yizhou Jiang, Allen Xue, Meg Elias, Jeff Aycock, Jeff Wiezorek, William Y. Go

    Argitaratua 2017
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy

    A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy nork Ranjan Upadhyay, Jonathan Boiarsky, Gvantsa Pantsulaia, Judit Svensson‐Arvelund, Matthew J. Lin, Aleksandra Wroblewska, Sherry Bhalla, Nathalie Scholler, Adrian Bot, John M. Rossi, Norah Sadek, Samir Parekh, Alessandro Laganá, Alessia Baccarini, Miriam Mérad, Brian D. Brown, Joshua Brody

    Argitaratua 2021
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma

    Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma nork Frederick L. Locke, John M. Rossi, Sattva S. Neelapu, Caron A. Jacobson, David B. Miklos, Armin Ghobadi, Olalekan O. Oluwole, Patrick M. Reagan, Lazaros J. Lekakis, Yi Lin, Marika Sherman, Marc Better, William Y. Go, Jeffrey S. Wiezorek, Allen Xue, Adrian Bot

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    IL7 increases targeted lipid nanoparticle–mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation

    IL7 increases targeted lipid nanoparticle–mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation nork Caitlin M. Tilsed, Barzan A. Sadiq, Tyler E. Papp, Phurin Areesawangkit, Kenji Kimura, Estela Noguera-Ortega, John Scholler, Nicholas Cerda, Haig Aghajanian, Adrian Bot, Barbara L. Mui, Ying K. Tam, Drew Weissman, Carl H. June, Steven Μ. Albelda, Hamideh Parhiz

    Argitaratua 2024
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses

    Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses nork Gabrielle Romain, Paolo Strati, Ali Rezvan, Mohsen Fathi, Irfan Bandey, Jay R T. Adolacion, Darren Heeke, Ivan Liadi, Mario L. Marques‐Piubelli, Luisa M. Solis, Ankit Mahendra, Francisco Vega, Laurence J.N. Cooper, Harjeet Singh, Mike Mattie, Adrian Bot, Sattva S. Neelapu, Navin Varadarajan

    Argitaratua 2022
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7)

    Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7) nork Simone Filosto, Saran Vardhanabhuti, Miguel Canales, Xavier Poiré, Lazaros J. Lekakis, Sven de Vos, Craig A. Portell, Zixing Wang, Christina To, Marco Schupp, Soumya Poddar, Tan Trinh, Carmen M. Warren, Ethan G. Aguilar, Justin A. Budka, Paul Cheng, Justin Chou, Adrian Bot, Rhine R. Shen, Jason R. Westin

    Argitaratua 2023
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma

    Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma nork Jennifer N. Brudno, Norris Lam, Danielle Vanasse, Yueh-wei Shen, Jeremy J. Rose, John M. Rossi, Allen Xue, Adrian Bot, Nathalie Scholler, Lekha Mikkilineni, Mark Roschewski, Robert M. Dean, Raúl E. Cachau, Philippe Youkharibache, Rashmika Patel, Brenna Hansen, David F. Stroncek, Steven A. Rosenberg, Ronald E. Gress, James N. Kochenderfer

    Argitaratua 2020
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma

    Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma nork Max S. Topp, Tom van Meerten, Roch Houot, Monique C. Minnema, Krimo Bouabdallah, Pieternella J. Lugtenburg, Catherine Thiéblemont, Martin Wermke, Kevin Song, Irit Avivi, John Kuruvilla, Ulrich Dührsen, Yan Zheng, Saran Vardhanabhuti, Jinghui Dong, Adrian Bot, John M. Rossi, Vicki Plaks, Marika Sherman, Jenny J. Kim, A. Kerber, Marie José Kersten

    Argitaratua 2021
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: